基本信息
views: 50
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Dr. Aragon-Ching is a specialty Oncology care physician board certified in medical oncology, hematology and internal medicine. She joined Inova Medical Group with more than 15 years of clinical experience. She has a special interest in management of genitourinary (GU) cancers (prostate, bladder, kidney and testicular cancers).
Prior to joining Inova Medical Group, Dr. Aragon-Ching served as an associate professor of medicine at the George Washington University School of Medicine and Health Sciences and has a clinical focus in the treatment and research of GU cancers at the George Washington University Medical Center, where she served in varying capacities as a principal investigator of various trials on drug treatment and biomarkers. She is a well-published author, educator, and serves on the Editorial Board of various academic journals. She has been recognized a "Top Doctor" by the Washingtonian since 2014.
Dr. Aragon-Ching serves as the clinical program director of Genitourinary Cancers within the Inova Schar Cancer Institute. In this capacity, she is excited to bring together the multidisciplinary program of excellence in the clinical care and research for patients with GU malignancies.
Prior to joining Inova Medical Group, Dr. Aragon-Ching served as an associate professor of medicine at the George Washington University School of Medicine and Health Sciences and has a clinical focus in the treatment and research of GU cancers at the George Washington University Medical Center, where she served in varying capacities as a principal investigator of various trials on drug treatment and biomarkers. She is a well-published author, educator, and serves on the Editorial Board of various academic journals. She has been recognized a "Top Doctor" by the Washingtonian since 2014.
Dr. Aragon-Ching serves as the clinical program director of Genitourinary Cancers within the Inova Schar Cancer Institute. In this capacity, she is excited to bring together the multidisciplinary program of excellence in the clinical care and research for patients with GU malignancies.
Research Interests
Papers共 179 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Current opinion in oncologyno. 3 (2024): 164-168
Translational andrology and urologyno. 4 (2024): 635-638
Journal of Clinical Oncologyno. 16_suppl (2024)
Exploration of Targeted Anti-tumor Therapyno. 4 (2024): 971-980
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2023): 58-59
Cited0Views0Bibtex
0
0
JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023): 4516-4516
JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023): e17075-e17075
Load More
Author Statistics
#Papers: 178
#Citation: 3630
H-Index: 29
G-Index: 58
Sociability: 6
Diversity: 3
Activity: 64
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn